RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. - Wikidata - awgldk - TriplyDB

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.

http://www.wikidata.org/entity/Q40290084

about

Progress toward in vivo use of siRNAs-II Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling.Mouse neuronal cells expressing exogenous bovine PRNP and simultaneous downregulation of endogenous mouse PRNP using siRNAs.Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight A robust in vivo positive-readout system for monitoring siRNA delivery to xenograft tumors.RNA interference for improving the outcome of islet transplantation.Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA Degradation of nuclease-stabilized RNA oligonucleotides in Mycoplasma-contaminated cell culture media.Oxime ether lipids containing hydroxylated head groups are more superior siRNA delivery agents than their nonhydroxylated counterparts.Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure.Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature.The versatility of oligonucleotides as potential therapeutics.Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice.Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.New aspects of gene-silencing for the treatment of cardiovascular diseases Nanovector delivery of siRNA for cancer therapy Use of liposomes as drug delivery vehicles for treatment of melanoma.Lipidic systems for in vivo siRNA delivery.Strategies for tumor-directed delivery of siRNA.Personalized cancer approach: using RNA interference technology.RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics Targeted therapies through microRNAs: pulp or fiction?Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.Delivery of RNAi therapeutics: work in progress.Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.Delivering the promise of small ncRNA therapeutics.Therapeutic potential of siRNA and DNAzymes in cancer.Tissue engineering and microRNAs: future perspectives in regenerative medicine.Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.Stacking up CRISPR against RNAi for therapeutic gene inhibition.The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment.Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.Biomaterials in siRNA Delivery: A Comprehensive Review.

P2860

Q28255877-724B78FC-718B-455F-AD79-3C2F6E8002DD Q28771711-2331CDFF-DEF8-467A-BDDA-5507F6ADC667 Q33587422-CB4C98A4-F97D-413C-9393-C8BC5514820D Q33772925-CAD1D092-C8BF-44E1-B3F1-F405FC9BCEE8 Q34049485-F6A197B6-E00B-4A2C-AEE6-57A985BA9290 Q34393539-800468AB-EFBE-46E3-A845-A962B43F0802 Q34706669-F8558EB3-995C-40F0-8399-27026D1FC570 Q34729434-3524970A-B8EA-4643-9673-343AB0131899 Q35374908-0F65FEC0-5C20-4DFA-8163-89FFF83B04BE Q35665154-40EE18D6-22B3-48F4-8732-264AF981BB69 Q35764362-EDD9844A-8592-4C84-8B62-236747E6F4FA Q35867148-2B3B7CD5-1067-4E97-A1B1-2AA68959EF00 Q36257158-6AC66581-95E0-4B3A-B8F0-A2EC6BE708BF Q36438289-6625F98F-FC73-4BE1-87CD-8480F3E80A21 Q36739639-C013A017-D9C1-43F5-BCBA-0F99CE13D6DE Q36781516-3FF8FB13-B0D9-4D7A-AD96-71D520CA24B6 Q36897394-B74DF98E-1E69-477B-9571-71A9FF58CE08 Q37111373-AC5A74EA-F1A1-4F1C-BBF1-E0F9C60C3ACE Q37193000-F96BD802-EBDF-4DB0-91CE-3ADB520ABB33 Q37277425-F5FE4B73-A410-4BDE-B7E4-CE05ADE07766 Q37347097-702BF2C3-81FC-445D-9BD9-4A77CD7FF41A Q37406217-957000EF-2CAD-4C16-A7DB-0F669FE6329B Q37598096-0E1D4E67-D09C-4C99-B034-35AB009A5DBF Q37840092-E84F239D-40EF-4AA2-B402-9734AE226805 Q37873825-33EE5B31-B14A-4EED-AE71-0EF9D6540E33 Q38019046-B28AB5B3-E0A8-4F98-A4E0-044C6B8670BD Q38095966-95D362AD-9E6F-4781-B6B8-8E60CF432FA1 Q38098811-4C92B58B-9928-4608-9486-9AB17781BE6E Q38160246-1277E32D-D63C-47F1-9B54-F19922F39786 Q38162098-43A38F6C-520D-4E61-8D08-430B20BB0E3F Q38217461-5AFDDF51-AB82-4F10-AB7A-AC9A90B727E5 Q38226666-CFCEFACC-7C5A-4E0D-B677-8FC7F3D1C7D7 Q38242397-05A6B2A4-0BA8-4FF1-909E-DE1E1AFED604 Q38552026-4DD5AC10-2BD9-4F9F-B031-CD26216764B2 Q38692510-3DC59303-7CF6-4A2E-975A-1FA313600E73 Q38811165-3B45B3D3-C106-4805-BEF3-D5484BA40723 Q38819540-BB06F9C5-5305-40F1-81AF-81019B2128E7 Q38871314-E74C39F9-4B48-464A-9039-38827ACC24DE Q38872103-31210274-C53F-4B17-8251-BD98C2C188F9 Q38971775-742DBAB4-2781-472E-A227-BD38E92F2265

P2860

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.

http://www.wikidata.org/entity/Q40290084

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

RNA interference in the mouse ...... lipoplexes for cancer therapy.

@en

type

label

RNA interference in the mouse ...... lipoplexes for cancer therapy.

@en

prefLabel

RNA interference in the mouse ...... lipoplexes for cancer therapy.

@en

P1433

Q40290084-7AE9811C-2AE0-4A8E-9E6B-0F6656ACB2E7

P1476

Q40290084-C9408CC7-5FFE-4419-829B-79DB9D9D1E83

P2093

Q40290084-07254382-5206-47FD-A4A3-DF400738266A

Q40290084-0B031F21-CC83-480E-9B1F-3D5EA6659974

Q40290084-0B407F65-C12C-47FA-BE8C-0FA04B1B8C34

Q40290084-4DCA1CA2-1B13-4360-902D-2A684643A653

Q40290084-76AEC390-63A8-4CBF-8E57-2F4B08277260

Q40290084-89D601EE-9B58-44FC-B55B-7560B09D1F6F

Q40290084-8DB7CCE7-8D1C-4B37-988D-ECCF16F53BFD

Q40290084-8DC9D39D-A3E0-45D1-B407-97AF143296E9

Q40290084-9D407ABB-F2B4-41D3-99D3-194311B1E7CF

Q40290084-BA543955-D42A-4006-816F-7627B964AC47

P2860

Q40290084-0ED36A20-B42A-456A-9C9B-E8979699301F

Q40290084-41F987FA-30CF-4FF9-AB76-A871580BDD73

Q40290084-46676245-3E0D-4B1A-B36F-D914EC2086C2

Q40290084-4A0EB373-8856-44DB-8324-869684EC73EA

Q40290084-4F920462-C3CE-47E5-BF66-C0FA2BFB2169

Q40290084-57A62F91-6875-4072-A1B1-FCA88B961CF1

Q40290084-5FFA0A52-106B-46C2-9C1F-A50F0BF48D8F

Q40290084-6803D01C-14A1-4BAC-B771-5D41F011C063

Q40290084-6A2AA590-65EB-4FAF-B1C7-D69A586AA2C7

Q40290084-74B5A5DD-EBC9-4A36-984C-0C2E90F61E92

P2888

Q40290084-260009C4-F1BA-44B0-A6A5-73C78A8DA46E

P304

Q40290084-5F84C1B5-65AA-48DE-86AD-8FE424E3115A

P31

Q40290084-9BBE7F7F-5E2A-4E2C-8B5A-C61160D1E21A

P356

Q40290084-C388D962-57D0-42F3-AB85-3BFB72F816E2

P433

Q40290084-83B19ECB-D39D-42E0-A052-B293739CA311

P478

Q40290084-2F262D5E-457C-4290-AC81-8BEF2F5002D7

P577

Q40290084-21AAD5CB-691E-4AA6-B8DD-D24812E15191

P5875

Q40290084-C6FE086F-83D2-43F6-B1C2-1CBDA60AD9B8

P6179

Q40290084-22E1ABC8-F786-421B-B26B-B41191599CB7

P698

Q40290084-80598F26-3F49-4137-850D-39457BF03128

P921

Q40290084-D9181C3F-9858-47BB-965C-5D4C44096638

P356

P1433

P1476

RNA interference in the mouse ...... lipoplexes for cancer therapy.

@en

P2093

Aleku M

http://www.w3.org/2001/XMLSchema#string

Arnold W

http://www.w3.org/2001/XMLSchema#string

Dames S

http://www.w3.org/2001/XMLSchema#string

Durieux B

http://www.w3.org/2001/XMLSchema#string

Endruschat J

http://www.w3.org/2001/XMLSchema#string

Esche V

http://www.w3.org/2001/XMLSchema#string

Fechtner M

http://www.w3.org/2001/XMLSchema#string

Fisch G

http://www.w3.org/2001/XMLSchema#string

Giese K

http://www.w3.org/2001/XMLSchema#string

Kaufmann J

http://www.w3.org/2001/XMLSchema#string

P2860

PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

The biology of VEGF and its receptors

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

PECAM-1: old friend, new partners

Killing the messenger: short RNAs that silence gene expression

RNA interference and potential therapeutic applications of short interfering RNAs

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

P2888

P304

1360-1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3302778

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7155706

http://www.w3.org/2001/XMLSchema#string

P6179

1007289041

http://www.w3.org/2001/XMLSchema#string

P698

16625242

http://www.w3.org/2001/XMLSchema#string

P921